Observational studyClinical & experimental ophthalmology2025

Outcomes After Switching to Faricimab in Neovascular Age-Related Macular Degeneration: Data From the Fight Retinal Blindness! Registry.

Adrian Hunt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.